<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109387">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02066064</url>
  </required_header>
  <id_info>
    <org_study_id>G-EYE</org_study_id>
    <nct_id>NCT02066064</nct_id>
  </id_info>
  <brief_title>G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist</brief_title>
  <official_title>G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate - Randomized Tandem Study With Different Endoscopist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smart Medical Systems Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smart Medical Systems Ltd.</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the adenoma detection rate of G-EYE™ high definition
      colonoscopy with that of standard high definition colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single Center, two-arm, randomized , open-label study with different and blinded
      endoscopists.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>G-EYE™ colonoscopy detection rate of adenomas and serrated lesions compared to the standard colonoscopy detection rate of the same.</measure>
    <time_frame>estimated 14 days (following histology results)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>polyp and adenoma detection, procedure times and safety</measure>
    <time_frame>24-72 hours post procedure</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Adenoma</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo complete standard colonoscopy,  followed by G-EYE(TM) Colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will undergo G-EYE(TM) colonoscopy followed by standard colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Colonoscopy</intervention_name>
    <description>Standard Colonoscopy</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>G-EYE(TM) Colonoscopy</intervention_name>
    <description>G-EYE(TM) Colonoscopy</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients over 50 years old

          2. Referred to colonoscopy for screening, following positive FOBT testing, change of
             bowel habits or for surveillance colonoscopy (history of adenoma resection).

          3. The patient must understand and provide written consent for the procedure.

        Exclusion Criteria:

          1. Subjects with inflammatory bowel disease;

          2. Subjects with a personal history of polyposis syndrome;

          3. Subjects with suspected chronic stricture potentially precluding complete
             colonoscopy;

          4. Subjects with diverticulitis or toxic megacolon;

          5. Subjects with a history of radiation therapy to abdomen or pelvis;

          6. Pregnant or lactating female subjects;

          7. Subjects who are currently enrolled in another clinical investigation.

          8. Subjects with current oral or parenteral use of anticoagulants

          9. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Kiesslich, Prof.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Arthur Hofmann, Dr.</last_name>
    <phone>(069) 1563-1287</phone>
    <email>AHoff66286@aol.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Marienkrankenhaus Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60318</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Hoffman, Dr.</last_name>
      <phone>(069) 1563-1287</phone>
    </contact>
    <investigator>
      <last_name>Ralf Kiesslich, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arthur Hoffman, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 16, 2014</lastchanged_date>
  <firstreceived_date>February 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal Cancer</keyword>
  <keyword>Adenoma</keyword>
  <keyword>Standard Colonoscopy</keyword>
  <keyword>G-EYE(TM) Colonoscopy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
